1-3 of 3
Haiyong Peng
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Potentiating CD20 monoclonal antibody therapy by targeting complement C3 fragment covalently deposited on lymphoma cells

Sivasubramanian Baskar, Haiyong Peng, Erika M Gaglione, Elizabeth J Carstens, Margaret A Lindorfer, Inhye E. Ahn, Sarah E.M. Herman, Martin Skarzynski, Jing Chang, Keyvan Keyvanfar, Vicent Butera, Amy Z Blackburn, Berengere Vire, Irina Maric, Maryalice Stetler-Stevenson, Constance M Yuan, Michael A Eckhaus, Susan Soto, Mohammed Z.H. Farooqui, Ronald P Taylor, Christoph Rader, Adrian Wiestner
Journal: Blood
Blood blood.2024024846.
https://doi.org/10.1182/blood.2024024846
Published: 2025
Includes: Supplemental data
Journal Articles

Targeting C3d in Combination with Daratumumab: a Strategy to Enhance Therapeutic Potential in Multiple Myeloma

Sivasubramanian Baskar, Haiyong Peng, Christoph Rader, Adrian Wiestner
Journal: Blood
Blood (2022) 140 (Supplement 1): 9989–9990.
https://doi.org/10.1182/blood-2022-166681
Published: 2022
Journal Articles

Evaluation of ROR1 Targeted Antibody Drug Conjugates in Acute and Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma

Eileen Hu, BS, Priscilla Do, Rajeswaran Mani, DVM,PhD, Frank Frissora, MS, Haiyong Peng, PhD, Lorenz Waldmeier, PhD, Roger Beerli, PhD, Christoph Rader, PhD, Ulf Grawunder, PhD, John C. Byrd, MD, Natarajan Muthusamy, DVM,PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3017.
https://doi.org/10.1182/blood.V130.Suppl_1.3017.3017
Published: 2017